Stock Events

Stock Events

Search...

iShares Genomics Immunology and Healthcare

$24.14

44

-$0.35-1.43% Today

Statistics

Day High

24.34

Day Low

24.14

52W High

25.7

52W Low

17.33

Volume

12,534

Avg. Volume

28,846

Mkt Cap

-

P/E Ratio

-

Dividend Yield

1.16%

Dividend

0.28

Upcoming

Dividend Payment

Dividend Payment

Dividend Payment

Dividend Payment

Dividends

1.16%Dividend Yield

10Y Growth

N/A

5Y Growth

3.16%

3Y Growth

-3.1%

1Y Growth

16.94%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow IDNA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

ARK Genomic Revolution

ARK Genomic Revolution ETF focuses on companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, genomics, and molecular diagnostics, directly competing with IDNA's focus on genomics and healthcare.

Global X Genomics & Biotechnology

Global X Genomics & Biotechnology ETF invests in companies involved in genomics and biotechnology, directly aligning with IDNA's investment in genomics and healthcare sectors.

VanEck Vectors Biotech ETF provides exposure to companies in the biotech industry, which overlaps significantly with the genomics, immunology, and healthcare focus of IDNA.

First Trust NYSE Arca Biotechnology Index Fund

First Trust NYSE Arca Biotechnology Index Fund tracks an index of biotechnology and pharmaceutical companies, competing with IDNA by investing in similar sectors of healthcare and biotech.

iShares Biotechnology

iShares Biotechnology ETF offers exposure to U.S. biotechnology and pharmaceutical companies, directly competing with IDNA's focus on the healthcare and genomics sectors.

SPDR S&P Biotech ETF provides exposure to the biotechnology sector, which includes companies involved in genomics and immunology, making it a direct competitor to IDNA.

Invesco Biotechnology & Genome

Invesco Dynamic Biotechnology & Genome ETF invests in companies that are principally engaged in the research, development, manufacturing, and distribution of various biotechnological products, therapies, and services, including those in genomics, competing directly with IDNA.

ALPS Medical Breakthroughs

ALPS Medical Breakthroughs ETF targets companies with one or more drugs in Phase II or Phase III FDA clinical trials, which overlaps with IDNA's focus on innovative healthcare and genomics companies.

iShares Self-Driving EV and Tech

iShares Self-Driving EV and Tech ETF, while focused on electric vehicles and technology, indirectly competes with IDNA by investing in technology advancements, including those that could impact healthcare and genomics through innovation in related technologies.

About

Miscellaneous

Investment Trusts/Mutual Funds

The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.

Show more...

CEO

Country

US

ISIN

US46435U1925

Listings